Stock to buy: The stock of pharmaceutical company SMS Pharmaceuticals is witnessing tremendous growth today. The company’s shares jumped up to 13% in early trade itself. Actually, SMS Pharmaceuticals has got the license to manufacture Corona Medicine. As soon as this news came, buying in the shares of the company has increased.
Let us inform that the current share price of SMS Pharmaceuticals is Rs 108.30. The share price of SMS Pharmaceuticals has risen by over Rs 12 on NSE today. At the same time, it has increased by 10.73 percent in the last five trading sessions.
Also read- This share of Rs 25 did wonders! ₹16 lakh made directly to 1 lakh of investors
information given by the company
Strides Pharma Science on Monday said it has entered into a sub-license agreement with the Medicines Patent Pool (MPP) for the commercialization of a generic version of Pfizer’s oral (ingestible) COVID-19 drug in 95 low- and middle-income countries. . The emergency use of this Pfizer product has been approved for adults and children with disease at high risk in the United States and other countries. It is an oral medicine i.e. it can be consumed.
Also read- These shares of Tata Group increased from ₹ 35 to ₹ 416, 1 lakh of investors became ₹ 11.81 lakh
Medicine will be ready in Bangalore
The drug, named ‘Covidax’, will be launched in 95 markets under the sub-license agreement with MPP, the company said in a statement. It will be manufactured at the company’s plant in Bangalore.
Arun Kumar, Founder, Strides Pharma Science, said, “This is part of our commitment to produce high quality drugs to fight the menace of COVID-19 across the world.”